Zymeworks Inc. financial data

Symbol
ZYME on Nasdaq
Industry
Pharmaceutical Preparations
Location
108 Patriot Drive, Suite A, Middletown, DE
Fiscal year end
December 31
Former names
Zymeworks Delaware Inc. (to 10/13/2022)
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 457 % -20.4%
Debt-to-equity 31.6 % +8.66%
Return On Equity -31.7 % -11.5%
Return On Assets -24 % -9.42%
Operating Margin -134 % +54.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 69.6M shares -1.41%
Common Stock, Shares, Outstanding 69.6M shares -1.55%
Entity Public Float 488M USD +4.18%
Common Stock, Value, Issued 1.02B USD +1.84%
Weighted Average Number of Shares Outstanding, Basic 75.2M shares -1.37%
Weighted Average Number of Shares Outstanding, Diluted 75.2M shares -1.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 93.4M USD +85.1%
Research and Development Expense 130M USD -32.4%
General and Administrative Expense 62.7M USD -9.51%
Costs and Expenses 218M USD +9.68%
Operating Income (Loss) -125M USD +15.9%
Nonoperating Income (Expense) 303K USD -83.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -107M USD +16.2%
Income Tax Expense (Benefit) 6.51M USD +561%
Net Income (Loss) Attributable to Parent -114M USD +9.76%
Earnings Per Share, Basic -1.5 USD/shares +15.7%
Earnings Per Share, Diluted -1.5 USD/shares +15.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76.2M USD -33.6%
Accounts Receivable, after Allowance for Credit Loss, Current 24.6M USD -20.5%
Assets, Current 306M USD -22.2%
Deferred Income Tax Assets, Net 4.85M USD +30.9%
Property, Plant and Equipment, Net 16.7M USD -12.1%
Operating Lease, Right-of-Use Asset 16.7M USD -2.02%
Goodwill 12M USD 0%
Assets 426M USD -23.2%
Employee-related Liabilities, Current 2.65M USD +4.61%
Contract with Customer, Liability, Current 23.5M USD +583%
Liabilities, Current 65.1M USD +14.4%
Contract with Customer, Liability, Noncurrent 14.6M USD -55.7%
Deferred Income Tax Liabilities, Net 4.82M USD +43.7%
Operating Lease, Liability, Noncurrent 15.2M USD -27.7%
Other Liabilities, Noncurrent 856K USD -46.3%
Liabilities 101M USD -13.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.41M USD +17.1%
Retained Earnings (Accumulated Deficit) -853M USD -20.3%
Stockholders' Equity Attributable to Parent 325M USD -25.8%
Liabilities and Equity 426M USD -23.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.41M USD +91%
Net Cash Provided by (Used in) Financing Activities 1.32M USD -38.2%
Net Cash Provided by (Used in) Investing Activities 12.2M USD
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 69.6M shares -1.55%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 10.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.2M USD -33.6%
Deferred Tax Assets, Valuation Allowance 249M USD +12.3%
Deferred Tax Assets, Gross 258M USD +9.73%
Operating Lease, Liability 18.4M USD -26.7%
Depreciation 981K USD -7.54%
Payments to Acquire Property, Plant, and Equipment 16K USD -91.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -112M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid 21.2M USD -28.3%
Property, Plant and Equipment, Gross 35.5M USD -12.4%
Operating Lease, Liability, Current 3.26M USD -21.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.75M USD -37.6%
Deferred Tax Assets, Operating Loss Carryforwards 658M USD +10.2%
Preferred Stock, Shares Issued 1 shares 0%
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 3.12M USD +1.24%
Operating Lease, Payments 3.86M USD -24.3%
Preferred Stock, Shares Outstanding 1 shares 0%
Amortization of Intangible Assets 1.62M USD +130%
Deferred Tax Assets, Net of Valuation Allowance 4.39M USD +21.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%